Omission of dexamethasone in paclitaxel premedication regimens: protocol of the multicentre, randomised, non-inferiority DEXASTOP trial

Introduction Standard premedication for paclitaxel-based chemotherapy includes dexamethasone and an histamine 1-antagonist to prevent hypersensitivity reactions (HSRs). However, the pharmacological rationale for dexamethasone is limited, and its use is associated with adverse effects such as hypergl...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Birgit C P Koch, Virgil A S H Dalm, Leontine E A M M Spierings, Michiel Zietse, Luuk C Aalders, Nikki De Rouw, Wouter Dercksen, Frederick W Thielen, Leni van Doorn, Roelof W F van Leeuwen
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	BMJ Publishing Group 2025-04-01
Σειρά:	BMJ Open
Διαθέσιμο Online:	https://bmjopen.bmj.com/content/15/4/e102770.full
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!